Value Bridge — HALIFAX MEDICAL CENTER
Current $-22M → Target $-10M (+$12.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-22.3M
Current EBITDA
$-9.8M
Target EBITDA
+$12.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.8M
Payer Mix Optimization
$6.8M
Cost to Collect Reduction
$2.3M
Clean Claim Improvement
$1.7M
Volume & Rate Growth
$11.4M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-22M to $-10M. The highest-impact lever is Volume & Rate Growth at $4.5M probability-weighted.
IC talking point: "We see $13M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $138M in equity value creation."